TransMedics Group, Inc. Common Stock, Value, Issued
TransMedics Group, Inc. (TMDX) had Common Stock, Value, Issued of $774.22 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-04
- 2026-06-30: Common Stock, Value, Issued $774.22M.
- 2026-03-31: Common Stock, Value, Issued $764.64M.
- 2025-12-31: Common Stock, Value, Issued $750.93M.
- 2025-09-30: Common Stock, Value, Issued $738.43M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $774.22M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $764.64M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $750.93M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $738.43M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $725.65M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $709.19M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $697.21M 10-K · filed 2026-02-24 |
| 2024-09-30 | $685.25M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $669.45M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $651.16M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $641.11M 10-K · filed 2025-02-27 |
| 2023-09-30 | $634.46M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $627.75M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $674.16M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $666.28M 10-K · filed 2024-02-27 |
| 2022-09-30 | $660.06M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $515.76M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $513.20M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $510.49M 10-K · filed 2023-02-27 |
| 2021-09-30 | $508.46M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $505.93M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $503.91M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $502.22M 10-K · filed 2022-03-01 |
| 2020-09-30 | $501.49M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $500.56M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $424.79M 10-Q · filed 2020-05-06 |
| 2019-12-28 | $424.13M 10-K · filed 2021-03-11 |
| 2019-03-30 | $1.00K 10-Q · filed 2019-06-12 |
| 2018-12-29 | $1.00K 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |